Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Neoplasms of the CNS

Free Subscription Articles published in Acta Neuropathol Retrieve available abstracts of 127 articles: HTML format

Single Articles

September 2024
1. NUECHTERLEIN N, Cimino S, Shelbourn A, Ha V, et al
   HOXD12 defines an age-related aggressive subtype of oligodendroglioma.
   Acta Neuropathol. 2024;148:41.
   PubMed     Abstract available
   
   
   
2. STEGAT L, Eckhardt A, Gocke A, Neyazi S, et al
   Integrated analyses reveal two molecularly and clinically distinct subtypes of H3 K27M-mutant diffuse midline gliomas with prognostic significance.
   Acta Neuropathol. 2024;148:40.
   PubMed     Abstract available
   
   
   
3. SOL N, Kooi EJ, Pages-Gallego M, Brandsma D, et al
   Glioblastoma, IDH-wildtype with primarily leptomeningeal localization diagnosed by nanopore sequencing of cell-free DNA from cerebrospinal fluid.
   Acta Neuropathol. 2024;148:35.
   PubMed    
   
   
   
4. HENCH J, Hultschig C, Bratic Hench I, Sadasivan H, et al
   Rapid brain lymphoma diagnostics through nanopore sequencing of cytology-negative cerebrospinal fluid.
   Acta Neuropathol. 2024;148:36.
   PubMed    
   
   
   August 2024
5. TERANISHI Y, Yurchenko A, Tran S, Sievers P, et al
   Correlation between natural history and multi-omics profiling of meningiomas in NF2-related schwannomatosis suggests role of methylation group and immune microenvironment in tumor growth rate.
   Acta Neuropathol. 2024;148:30.
   PubMed    
   
   
   
6. AN S, McCortney K, Walshon J, Leonard K, et al
   Methylation profiling of plasma cell-free DNA in pediatric brain tumor patients.
   Acta Neuropathol. 2024;148:29.
   PubMed    
   
   
   
7. LECLAIR NK, Lucas CG, Mirchia K, McCortney K, et al
   The RNA-binding protein IGF2BP1 regulates stability of mRNA transcribed from FOXM1 target genes in hypermitotic meningiomas.
   Acta Neuropathol. 2024;148:28.
   PubMed    
   
   
   
8. LE QUANG M, Trinquet A, Siegfried A, de Barros A, et al
   FGFR1 wild-type rosette-forming glioneuronal tumours.
   Acta Neuropathol. 2024;148:26.
   PubMed    
   
   
   
9. ZHANG KY, Parker M, Weber-Levine C, Kalluri A, et al
   ASXL1 inactivation and reduced H3K27me3 across central nervous system tumors.
   Acta Neuropathol. 2024;148:19.
   PubMed    
   
   
   
10. MAAS SLN, Hielscher T, Sievers P, Hovestadt V, et al
    Loss over 5% of chromosome 1p is a clinically relevant and applicable cut-off for increased risk of recurrence in meningioma.
    Acta Neuropathol. 2024;148:17.
    PubMed    
    
    
    July 2024
11. PRIESTERBACH-ACKLEY LP, Cordier F, de Witt Hamer P, Snijders TJ, et al
    Diffuse, IDH-wildtype gliomas in adults with minimal histological change and isolated TERT promoter mutation: not simply CNS WHO grade 4.
    Acta Neuropathol. 2024;148:12.
    PubMed    
    
    
    
12. SIEVERS P, Bielle F, Gobel K, Schrimpf D, et al
    Identification of a putative molecular subtype of adult-type diffuse astrocytoma with recurrent MAPK pathway alterations.
    Acta Neuropathol. 2024;148:7.
    PubMed    
    
    
    
13. RICHARDSON TE, Walker JM, Hambardzumyan D, Brem S, et al
    Genetic and epigenetic instability as an underlying driver of progression and aggressive behavior in IDH-mutant astrocytoma.
    Acta Neuropathol. 2024;148:5.
    PubMed     Abstract available
    
    
    June 2024
14. OKONECHNIKOV K, Schrimpf D, Koster J, Sievers P, et al
    Clinically unfavorable transcriptome subtypes of non-WNT/non-SHH medulloblastomas are associated with a predominance in proliferating and progenitor-like cell subpopulations.
    Acta Neuropathol. 2024;147:95.
    PubMed     Abstract available
    
    
    May 2024
15. LIN AL, Rudneva VA, Richards AL, Zhang Y, et al
    Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors.
    Acta Neuropathol. 2024;147:85.
    PubMed     Abstract available
    
    
    
16. SCHULLER U, Gocke A, Godbole S, Delbridge C, et al
    Anaplastic histology and distinct molecular features in a small series of spinal cord ependymomas.
    Acta Neuropathol. 2024;147:83.
    PubMed    
    
    
    April 2024
17. NASSIRI F, Ajisebutu A, Patil V, Mamatjan Y, et al
    Metabologenomic characterization uncovers a clinically aggressive IDH mutant glioma subtype.
    Acta Neuropathol. 2024;147:68.
    PubMed     Abstract available
    
    
    March 2024
18. REDMER T, Schumann E, Peters K, Weidemeier ME, et al
    Correction to: MET receptor serves as a promising target in melanoma brain metastases.
    Acta Neuropathol. 2024;147:63.
    PubMed    
    
    
    
19. ZAKIMI N, Nguyen MP, Raleigh DR
    Gene transcript fusions are associated with clinical outcomes and molecular groups of meningiomas.
    Acta Neuropathol. 2024;147:57.
    PubMed    
    
    
    February 2024
20. REDMER T, Schumann E, Peters K, Weidemeier ME, et al
    MET receptor serves as a promising target in melanoma brain metastases.
    Acta Neuropathol. 2024;147:44.
    PubMed     Abstract available
    
    
    
21. HARMANCI AS, Boudreau B, Lau S, Hosseingholi Nouri S, et al
    Aggressive human MenG C meningiomas have a molecular counterpart in canines.
    Acta Neuropathol. 2024;147:42.
    PubMed    
    
    
    
22. ZAKIMI N, Mazcko CN, Toedebusch C, Tawa G, et al
    Canine meningiomas are comprised of 3 DNA methylation groups that resemble the molecular characteristics of human meningiomas.
    Acta Neuropathol. 2024;147:43.
    PubMed    
    
    
    
23. RAHMANZADE R, Sahm F
    Reply: pineal parenchymal tumors of intermediate differentiation: in need of a stringent definition to avoid confusion.
    Acta Neuropathol. 2024;147:35.
    PubMed    
    
    
    
24. VASILJEVIC A
    Pineal parenchymal tumors of intermediate differentiation: in need of a stringent definition to avoid confusion. Scientific commentary on 'Genetical and epigenetical profiling identifies two subgroups of pineal parenchymal tumors of intermediate diffe
    Acta Neuropathol. 2024;147:34.
    PubMed    
    
    
    January 2024
25. NEYAZI S, Yamazawa E, Hack K, Tanaka S, et al
    Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutation.
    Acta Neuropathol. 2024;147:22.
    PubMed     Abstract available
    
    
    
26. DREXLER R, Khatri R, Schuller U, Eckhardt A, et al
    Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma.
    Acta Neuropathol. 2024;147:21.
    PubMed     Abstract available
    
    
    
27. DOTTERMUSCH M, Ryba A, Ricklefs FL, Flitsch J, et al
    Pituitary neuroendocrine tumors with PIT1/SF1 co-expression show distinct clinicopathological and molecular features.
    Acta Neuropathol. 2024;147:16.
    PubMed     Abstract available
    
    
    December 2023
28. HADAD S, Gupta R, Oberheim Bush NA, Taylor JW, et al
    "De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade.
    Acta Neuropathol. 2023;147:3.
    PubMed     Abstract available
    
    
    
29. AUFFRET L, Ajlil Y, Tauziede-Espariat A, Kergrohen T, et al
    A new subtype of diffuse midline glioma, H3 K27 and BRAF/FGFR1 co-altered: a clinico-radiological and histomolecular characterisation.
    Acta Neuropathol. 2023;147:2.
    PubMed     Abstract available
    
    
    
30. HICKMAN RA, Gedvilaite E, Ptashkin R, Reiner AS, et al
    CDKN2A/B mutations and allele-specific alterations stratify survival outcomes in IDH-mutant astrocytomas.
    Acta Neuropathol. 2023;146:845-847.
    PubMed    
    
    
    
31. RAHMANZADE R, Pfaff E, Banan R, Sievers P, et al
    Genetical and epigenetical profiling identifies two subgroups of pineal parenchymal tumors of intermediate differentiation (PPTID) with distinct molecular, histological and clinical characteristics.
    Acta Neuropathol. 2023;146:853-856.
    PubMed    
    
    
    October 2023
32. MAAS SLN, Sievers P, Weber DC, Weller M, et al
    Independent prognostic impact of DNA methylation class and chromosome 1p loss in WHO grade 2 and 3 meningioma undergoing adjuvant high-dose radiotherapy: comprehensive molecular analysis of EORTC 22042-26042.
    Acta Neuropathol. 2023 Oct 19. doi: 10.1007/s00401-023-02642.
    PubMed    
    
    
    
33. ROBERTS HJ, Ji S, Picca A, Sanson M, et al
    Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations.
    Acta Neuropathol. 2023 Oct 18. doi: 10.1007/s00401-023-02640.
    PubMed    
    
    
    
34. PICARD D, Felsberg J, Langini M, Stachura P, et al
    Integrative multi-omics reveals two biologically distinct groups of pilocytic astrocytoma.
    Acta Neuropathol. 2023;146:551-564.
    PubMed     Abstract available
    
    
    September 2023
35. BOETTO J, Plu I, Ducos Y, Blouin A, et al
    Normal meninges harbor oncogenic somatic mutations in meningioma-driver genes.
    Acta Neuropathol. 2023 Sep 26. doi: 10.1007/s00401-023-02635.
    PubMed    
    
    
    
36. TRAN QT, Upadhyaya SA, Billups CA, Onar-Thomas A, et al
    DNA-methylation subgroups carry no prognostic significance in ATRT-SHH patients in clinical trial cohorts.
    Acta Neuropathol. 2023;146:543-545.
    PubMed    
    
    
    
37. JOHANN PD, Altendorf L, Efremova EM, Holsten T, et al
    Recurrent atypical teratoid/rhabdoid tumors (AT/RT) reveal discrete features of progression on histology, epigenetics, copy number profiling, and transcriptomics.
    Acta Neuropathol. 2023;146:527-541.
    PubMed     Abstract available
    
    
    August 2023
38. WIRSCHING HG, Felsberg J, Prummer M, Moisoiu V, et al
    Spatial immune profiling of glioblastoma identifies an inflammatory, perivascular phenotype associated with longer survival.
    Acta Neuropathol. 2023 Aug 13. doi: 10.1007/s00401-023-02617.
    PubMed    
    
    
    July 2023
39. WILLIAMS EA, Brastianos PK, Wakimoto H, Zolal A, et al
    A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4.
    Acta Neuropathol. 2023 Jul 31. doi: 10.1007/s00401-023-02609.
    PubMed     Abstract available
    
    
    June 2023
40. MEDICI G, Freudenmann LK, Velz J, Wang SS, et al
    A T-cell antigen atlas for meningioma: novel options for immunotherapy.
    Acta Neuropathol. 2023 Jun 27. doi: 10.1007/s00401-023-02605.
    PubMed     Abstract available
    
    
    
41. MADLENER S, Furtner J, Stepien N, Senfter D, et al
    Clinical applicability of miR517a detection in liquid biopsies of ETMR patients.
    Acta Neuropathol. 2023;145:843-846.
    PubMed    
    
    
    May 2023
42. WANG JZ, Patil V, Liu J, Dogan H, et al
    Correction: Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas.
    Acta Neuropathol. 2023 May 12. doi: 10.1007/s00401-023-02584.
    PubMed    
    
    
    April 2023
43. KORSHUNOV A, Okonechnikov K, Schrimpf D, Tonn S, et al
    Transcriptome analysis stratifies second-generation non-WNT/non-SHH medulloblastoma subgroups into clinically tractable subtypes.
    Acta Neuropathol. 2023 Apr 24. doi: 10.1007/s00401-023-02575.
    PubMed     Abstract available
    
    
    
44. WANG JZ, Patil V, Liu J, Dogan H, et al
    Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas.
    Acta Neuropathol. 2023 Apr 24. doi: 10.1007/s00401-023-02571.
    PubMed     Abstract available
    
    
    
45. GODDARD J, Castle J, Southworth E, Fletcher A, et al
    Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification.
    Acta Neuropathol. 2023 Apr 4. doi: 10.1007/s00401-023-02566.
    PubMed     Abstract available
    
    
    March 2023
46. BOGUMIL H, Sill M, Schrimpf D, Ismer B, et al
    Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions.
    Acta Neuropathol. 2023 Mar 18. doi: 10.1007/s00401-023-02558.
    PubMed     Abstract available
    
    
    
47. JAMSHIDI P, McCord M, Galbraith K, Santana-Santos L, et al
    Variant allelic frequency of driver mutations predicts success of genomic DNA methylation classification in central nervous system tumors.
    Acta Neuropathol. 2023;145:365-367.
    PubMed    
    
    
    February 2023
48. KHAN AB, English CW, Chen WC, Athukuri P, et al
    Even heterozygous loss of CDKN2A/B greatly accelerates recurrence in aggressive meningioma.
    Acta Neuropathol. 2023 Feb 2. doi: 10.1007/s00401-023-02543.
    PubMed    
    
    
    
49. TANG V, Lu R, Mirchia K, Van Ziffle J, et al
    Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas.
    Acta Neuropathol. 2023 Feb 1. doi: 10.1007/s00401-023-02544.
    PubMed    
    
    
    January 2023
50. KECK MK, Sill M, Wittmann A, Joshi P, et al
    Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.
    Acta Neuropathol. 2023;145:49-69.
    PubMed     Abstract available
    
    
    
51. CIMINO PJ, Ketchum C, Turakulov R, Singh O, et al
    Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1.
    Acta Neuropathol. 2023;145:71-82.
    PubMed     Abstract available
    
    
    
52. METAIS A, Bouchoucha Y, Kergrohen T, Dangouloff-Ros V, et al
    Pediatric spinal pilocytic astrocytomas form a distinct epigenetic subclass from pilocytic astrocytomas of other locations and diffuse leptomeningeal glioneuronal tumours.
    Acta Neuropathol. 2023;145:83-95.
    PubMed     Abstract available
    
    
    December 2022
53. EBRAHIMI A, Herrlinger U, Waha A, Kaluza L, et al
    Methylation class oligosarcoma may encompass IDH-wildtype gliomas.
    Acta Neuropathol. 2022 Dec 15. doi: 10.1007/s00401-022-02529.
    PubMed    
    
    
    
54. MYNAREK M, Obrecht D, Sill M, Sturm D, et al
    Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohorts.
    Acta Neuropathol. 2022 Dec 2. doi: 10.1007/s00401-022-02522.
    PubMed     Abstract available
    
    
    
55. CHIANG J, Moreira DC, Li X, Furtado LV, et al
    Prognostic significance of chromosome arm 1q gain and methylation class in molecularly defined diffuse leptomeningeal glioneuronal tumor.
    Acta Neuropathol. 2022;144:1185-1187.
    PubMed    
    
    
    
56. TAUZIEDE-ESPARIAT A, Volodia-Dangouloff-Ros, Figarella-Branger D, Uro-Coste E, et al
    Clinicopathological and molecular characterization of three cases classified by DNA-methylation profiling as "Glioneuronal Tumors, NOS, Subtype A".
    Acta Neuropathol. 2022;144:1179-1183.
    PubMed    
    
    
    November 2022
57. GOTTARDO NG
    Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas: "it's a numbers game"-implications for WNT medulloblastoma dose-reduction clinical trials.
    Acta Neuropathol. 2022 Nov 20. doi: 10.1007/s00401-022-02518.
    PubMed    
    
    
    October 2022
58. WU Z, Rajan S, Chung HJ, Raffeld M, et al
    Molecular and clinicopathologic characteristics of gliomas with EP300::BCOR fusions.
    Acta Neuropathol. 2022 Oct 6. pii: 10.1007/s00401-022-02508.
    PubMed    
    
    
    
59. LIU APY, Dhanda SK, Lin T, Sioson E, et al
    Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center SJYC07 and SJMB03 clinical trials.
    Acta Neuropathol. 2022;144:733-746.
    PubMed     Abstract available
    
    
    
60. MESSIAEN J, Claeys A, Shetty A, Spans L, et al
    Generation of patient-derived models from a metastatic pediatric diffuse leptomeningeal glioneuronal tumor with KIAA1549::BRAF fusion.
    Acta Neuropathol. 2022;144:793-797.
    PubMed    
    
    
    
61. GOSCHZIK T, Mynarek M, Doerner E, Schenk A, et al
    Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas.
    Acta Neuropathol. 2022 Oct 1. pii: 10.1007/s00401-022-02505.
    PubMed     Abstract available
    
    
    September 2022
62. TATARI N, Khan S, Livingstone J, Zhai K, et al
    The proteomic landscape of glioblastoma recurrence reveals novel and targetable immunoregulatory drivers.
    Acta Neuropathol. 2022 Sep 30. pii: 10.1007/s00401-022-02506.
    PubMed     Abstract available
    
    
    
63. RICKLEFS FL, Fita KD, Mohme M, Mawrin C, et al
    Genetic and epigenetic profiling identifies two distinct classes of spinal meningiomas.
    Acta Neuropathol. 2022 Sep 27. pii: 10.1007/s00401-022-02504.
    PubMed    
    
    
    
64. SIDDAWAY R, Canty L, Pajovic S, Milos S, et al
    Oncohistone interactome profiling uncovers contrasting oncogenic mechanisms and identifies potential therapeutic targets in high grade glioma.
    Acta Neuropathol. 2022 Sep 7. pii: 10.1007/s00401-022-02489.
    PubMed     Abstract available
    
    
    August 2022
65. DOGAN H, Blume C, Patel A, Jungwirth G, et al
    Single-cell DNA sequencing reveals order of mutational acquisition in TRAF7/AKT1 and TRAF7/KLF4 mutant meningiomas.
    Acta Neuropathol. 2022 Aug 19. pii: 10.1007/s00401-022-02485.
    PubMed    
    
    
    
66. LUCAS CG, Sloan EA, Gupta R, Wu J, et al
    Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.
    Acta Neuropathol. 2022 Aug 9. pii: 10.1007/s00401-022-02478.
    PubMed     Abstract available
    
    
    
67. HUA L, Alkhatib M, Podlesek D, Gunther L, et al
    Two predominant molecular subtypes of spinal meningioma: thoracic NF2-mutant tumors strongly associated with female sex, and cervical AKT1-mutant tumors originating ventral to the spinal cord.
    Acta Neuropathol. 2022 Aug 9. pii: 10.1007/s00401-022-02474.
    PubMed    
    
    
    
68. PRATT D, Lucas CG, Selvam PP, Abdullaev Z, et al
    Recurrent ACVR1 mutations in posterior fossa ependymoma.
    Acta Neuropathol. 2022;144:373-376.
    PubMed    
    
    
    July 2022
69. DANILENKO M, Zaka M, Keeling C, Crosier S, et al
    Single-cell DNA sequencing identifies risk-associated clonal complexity and evolutionary trajectories in childhood medulloblastoma development.
    Acta Neuropathol. 2022 Jul 13. pii: 10.1007/s00401-022-02464.
    PubMed     Abstract available
    
    
    June 2022
70. KORSHUNOV A, Okonechnikov K, Stichel D, Schrimpf D, et al
    Gene expression profiling of Group 3 medulloblastomas defines a clinically tractable stratification based on KIRREL2 expression.
    Acta Neuropathol. 2022 Jun 30. pii: 10.1007/s00401-022-02460.
    PubMed     Abstract available
    
    
    
71. VASUDEVAN HN, Choudhury A, Hilz S, Villanueva-Meyer JE, et al
    Intratumor and informatic heterogeneity influence meningioma molecular classification.
    Acta Neuropathol. 2022 Jun 27. pii: 10.1007/s00401-022-02455.
    PubMed    
    
    
    
72. ADEBERG S, Knoll M, Koelsche C, Bernhardt D, et al
    DNA-methylome-assisted classification of patients with poor prognostic subventricular zone associated IDH-wildtype glioblastoma.
    Acta Neuropathol. 2022 Jun 4. pii: 10.1007/s00401-022-02443.
    PubMed     Abstract available
    
    
    
73. FEDERICO A, Thomas C, Miskiewicz K, Woltering N, et al
    ATRT-SHH comprises three molecular subgroups with characteristic clinical and histopathological features and prognostic significance.
    Acta Neuropathol. 2022;143:697-711.
    PubMed     Abstract available
    
    
    May 2022
74. WU Z, Lopes Abath Neto O, Bale TA, Benhamida J, et al
    DNA methylation analysis of glioblastomas harboring FGFR3-TACC3 fusions identifies a methylation subclass with better patient survival.
    Acta Neuropathol. 2022 May 14. pii: 10.1007/s00401-022-02430.
    PubMed    
    
    
    
75. PATEL A, Dogan H, Payne A, Krause E, et al
    Rapid-CNS(2): rapid comprehensive adaptive nanopore-sequencing of CNS tumors, a proof-of-concept study.
    Acta Neuropathol. 2022;143:609-612.
    PubMed    
    
    
    April 2022
76. FLASCH DA, Chen X, Ju B, Li X, et al
    Somatic LINE-1 promoter acquisition drives oncogenic FOXR2 activation in pediatric brain tumor.
    Acta Neuropathol. 2022 Apr 11. pii: 10.1007/s00401-022-02420.
    PubMed    
    
    
    
77. ROOSEN M, Ode Z, Bunt J, Kool M, et al
    The oncogenic fusion landscape in pediatric CNS neoplasms.
    Acta Neuropathol. 2022;143:427-451.
    PubMed     Abstract available
    
    
    March 2022
78. LIU AP, Li KK, Chow C, Chan S, et al
    Expanding the clinical and molecular spectrum of pituitary blastoma.
    Acta Neuropathol. 2022;143:415-417.
    PubMed    
    
    
    February 2022
79. TAUZIEDE-ESPARIAT A, Guerrini-Rousseau L, Perrier A, Torrejon J, et al
    Immunohistochemistry as a tool to identify ELP1-associated medulloblastoma.
    Acta Neuropathol. 2022 Feb 23. pii: 10.1007/s00401-022-02409.
    PubMed    
    
    
    
80. PRATT D, Abdullaev Z, Papanicolau-Sengos A, Ketchum C, et al
    High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13.
    Acta Neuropathol. 2022 Feb 1. pii: 10.1007/s00401-022-02404.
    PubMed     Abstract available
    
    
    
81. SUWALA AK, Felix M, Friedel D, Stichel D, et al
    Oligosarcomas, IDH-mutant are distinct and aggressive.
    Acta Neuropathol. 2022;143:263-281.
    PubMed     Abstract available
    
    
    January 2022
82. MARKWELL SM, Ross JL, Olson CL, Brat DJ, et al
    Necrotic reshaping of the glioma microenvironment drives disease progression.
    Acta Neuropathol. 2022 Jan 17. pii: 10.1007/s00401-021-02401.
    PubMed     Abstract available
    
    
    
83. LUCAS CG, Gupta R, Wu J, Shah K, et al
    EWSR1-BEND2 fusion defines an epigenetically distinct subtype of astroblastoma.
    Acta Neuropathol. 2022;143:109-113.
    PubMed    
    
    
    
84. JENSEIT A, Camgoz A, Pfister SM, Kool M, et al
    EZHIP: a new piece of the puzzle towards understanding pediatric posterior fossa ependymoma.
    Acta Neuropathol. 2022;143:1-13.
    PubMed     Abstract available
    
    
    December 2021
85. LUCAS CG, Abdullaev Z, Bruggers CS, Mirchia K, et al
    Activating NTRK2 and ALK receptor tyrosine kinase fusions extend the molecular spectrum of pleomorphic xanthoastrocytomas of early childhood: a diagnostic overlap with infant-type hemispheric glioma.
    Acta Neuropathol. 2021 Dec 15. pii: 10.1007/s00401-021-02396.
    PubMed    
    
    
    
86. CHONG AS, Han H, Albrecht S, Weon YC, et al
    DICER1 syndrome in a young adult with pituitary blastoma.
    Acta Neuropathol. 2021;142:1071-1076.
    PubMed    
    
    
    
87. SCHMID S, Solomon DA, Perez E, Thieme A, et al
    Genetic and epigenetic characterization of posterior pituitary tumors.
    Acta Neuropathol. 2021;142:1025-1043.
    PubMed     Abstract available
    
    
    November 2021
88. ALHALABI KT, Stichel D, Sievers P, Peterziel H, et al
    PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum.
    Acta Neuropathol. 2021;142:841-857.
    PubMed     Abstract available
    
    
    
89. SIEVERS P, Henneken SC, Blume C, Sill M, et al
    Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors.
    Acta Neuropathol. 2021;142:827-839.
    PubMed     Abstract available
    
    
    September 2021
90. SIEVERS P, Stichel D, Sill M, Schrimpf D, et al
    GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types.
    Acta Neuropathol. 2021 Sep 18. pii: 10.1007/s00401-021-02369.
    PubMed    
    
    
    
91. KIRCHES E, Sahm F, Korshunov A, Bluecher C, et al
    Molecular profiling of pediatric meningiomas shows tumor characteristics distinct from adult meningiomas.
    Acta Neuropathol. 2021 Sep 8. pii: 10.1007/s00401-021-02351.
    PubMed     Abstract available
    
    
    
92. GUPTA R, Lucas CG, Wu J, Barreto J, et al
    Low-grade glioneuronal tumors with FGFR2 fusion resolve into a single epigenetic group corresponding to 'Polymorphous low-grade neuroepithelial tumor of the young'.
    Acta Neuropathol. 2021;142:595-599.
    PubMed    
    
    
    August 2021
93. COLTIN H, Sundaresan L, Smith KS, Skowron P, et al
    Subgroup and subtype-specific outcomes in adult medulloblastoma.
    Acta Neuropathol. 2021 Aug 18. pii: 10.1007/s00401-021-02358.
    PubMed     Abstract available
    
    
    
94. LOTSCH D, Kirchhofer D, Englinger B, Jiang L, et al
    Targeting fibroblast growth factor receptors to combat aggressive ependymoma.
    Acta Neuropathol. 2021;142:339-360.
    PubMed     Abstract available
    
    
    
95. PATHAK R, Zin F, Thomas C, Bens S, et al
    Inhibition of nuclear export restores nuclear localization and residual tumor suppressor function of truncated SMARCB1/INI1 protein in a molecular subset of atypical teratoid/rhabdoid tumors.
    Acta Neuropathol. 2021;142:361-374.
    PubMed     Abstract available
    
    
    July 2021
96. NAZIO F, Po A, Abballe L, Ballabio C, et al
    Targeting cancer stem cells in medulloblastoma by inhibiting AMBRA1 dual function in autophagy and STAT3 signalling.
    Acta Neuropathol. 2021 Jul 24. pii: 10.1007/s00401-021-02347.
    PubMed     Abstract available
    
    
    
97. SCHOOF M, Kordes U, Volk AE, Al-Kershi S, et al
    Malignant gliomas with H3F3A G34R mutation or MYCN amplification in pediatric patients with Li Fraumeni syndrome.
    Acta Neuropathol. 2021 Jul 15. pii: 10.1007/s00401-021-02346.
    PubMed    
    
    
    June 2021
98. FUJIMOTO K, Arita H, Satomi K, Yamasaki K, et al
    TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma.
    Acta Neuropathol. 2021 Jun 20. pii: 10.1007/s00401-021-02337.
    PubMed     Abstract available
    
    
    
99. KRESBACH C, Dorostkar MM, Suwala AK, Wefers AK, et al
    Neurofibromatosis type 2 predisposes to ependymomas of various localization, histology, and molecular subtype.
    Acta Neuropathol. 2021;141:971-974.
    PubMed    
    
    
    
100. THOMAS C, Thierfelder F, Trager M, Soschinski P, et al
     TERT promoter mutation and chromosome 6 loss define a high-risk subtype of ependymoma evolving from posterior fossa subependymoma.
     Acta Neuropathol. 2021;141:959-970.
     PubMed     Abstract available
     
     
     
101. TESILEANU CMS, Vallentgoed WR, Sanson M, Taal W, et al
     Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations.
     Acta Neuropathol. 2021;141:945-957.
     PubMed     Abstract available
     
     
     
102. NADAF J, de Kock L, Chong AS, Korbonits M, et al
     Molecular characterization of DICER1-mutated pituitary blastoma.
     Acta Neuropathol. 2021;141:929-944.
     PubMed     Abstract available
     
     
     May 2021
103. JAUNMUKTANE Z, Banerjee G, Paine S, Parry-Jones A, et al
     Alzheimer's disease neuropathological change three decades after iatrogenic amyloid-beta transmission.
     Acta Neuropathol. 2021 May 28. pii: 10.1007/s00401-021-02326.
     PubMed    
     
     
     
104. LIU APY, Li BK, Pfaff E, Gudenas B, et al
     Clinical and molecular heterogeneity of pineal parenchymal tumors: a consensus study.
     Acta Neuropathol. 2021;141:771-785.
     PubMed     Abstract available
     
     
     April 2021
105. FORSTER A, Brand F, Banan R, Huneburg R, et al
     Rare germline variants in the E-cadherin gene CDH1 are associated with the risk of brain tumors of neuroepithelial and epithelial origin.
     Acta Neuropathol. 2021 Apr 30. pii: 10.1007/s00401-021-02307.
     PubMed     Abstract available
     
     
     
106. SUWALA AK, Stichel D, Schrimpf D, Maas SLN, et al
     Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1.
     Acta Neuropathol. 2021 Apr 19. pii: 10.1007/s00401-021-02302.
     PubMed     Abstract available
     
     
     
107. RICKERT D, Bartl J, Picard D, Bernardi F, et al
     Circular RNA profiling distinguishes medullobastoma groups and shows aberrant RMST overexpression in WNT medulloblastoma.
     Acta Neuropathol. 2021 Apr 17. pii: 10.1007/s00401-021-02306.
     PubMed    
     
     
     
108. PRATT D, Kumar-Sinha C, Cieslik M, Mehra R, et al
     A novel ATXN1-DUX4 fusion expands the spectrum of 'CIC-rearranged sarcoma' of the CNS to include non-CIC alterations.
     Acta Neuropathol. 2021;141:619-622.
     PubMed    
     
     
     March 2021
109. ZSCHERNACK V, Junger ST, Mynarek M, Rutkowski S, et al
     Supratentorial ependymoma in childhood: more than just RELA or YAP.
     Acta Neuropathol. 2021;141:455-466.
     PubMed     Abstract available
     
     
     February 2021
110. FISHER MJ, Jones DTW, Li Y, Guo X, et al
     Integrated molecular and clinical analysis of low-grade gliomas in children with neurofibromatosis type 1 (NF1).
     Acta Neuropathol. 2021 Feb 14. pii: 10.1007/s00401-021-02276.
     PubMed     Abstract available
     
     
     
111. SCHULLER U, Iglauer P, Dorostkar MM, Mawrin C, et al
     Correction to: Mutations within FGFR1 are associated with superior outcome in a series of 83 diffuse midline gliomas with H3F3A K27M mutations.
     Acta Neuropathol. 2021 Feb 9. pii: 10.1007/s00401-021-02273.
     PubMed    
     
     
     
112. HOLDHOF D, Johann PD, Spohn M, Bockmayr M, et al
     Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases.
     Acta Neuropathol. 2021;141:291-301.
     PubMed     Abstract available
     
     
     January 2021
113. SCHULLER U, Iglauer P, Dorostkar MM, Mawrin C, et al
     Mutations within FGFR1 are associated with superior outcome in a series of 83 diffuse midline gliomas with H3F3A K27M mutations.
     Acta Neuropathol. 2021 Jan 12. pii: 10.1007/s00401-020-02259.
     PubMed    
     
     
     
114. FUKUMURA K, Malgulwar PB, Fischer GM, Hu X, et al
     Multi-omic molecular profiling reveals potentially targetable abnormalities shared across multiple histologies of brain metastasis.
     Acta Neuropathol. 2021 Jan 4. pii: 10.1007/s00401-020-02256.
     PubMed     Abstract available
     
     
     
115. BALE TA, Sait SF, Benhamida J, Ptashkin R, et al
     Malignant transformation of a polymorphous low grade neuroepithelial tumor of the young (PLNTY).
     Acta Neuropathol. 2021;141:123-125.
     PubMed    
     
     
     
116. SUWALA AK, Stichel D, Schrimpf D, Kloor M, et al
     Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis.
     Acta Neuropathol. 2021;141:85-100.
     PubMed     Abstract available
     
     
     December 2020
117. SIEVERS P, Sill M, Blume C, Tauziede-Espariat A, et al
     Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1.
     Acta Neuropathol. 2020 Dec 14. pii: 10.1007/s00401-020-02247.
     PubMed     Abstract available
     
     
     October 2020
118. KEENAN C, Graham RT, Harreld JH, Lucas JT Jr, et al
     Infratentorial C11orf95-fused gliomas share histologic, immunophenotypic, and molecular characteristics of supratentorial RELA-fused ependymoma.
     Acta Neuropathol. 2020 Oct 24. pii: 10.1007/s00401-020-02238.
     PubMed    
     
     
     
119. PASSOS J, Quidet M, Brahimi A, Flament C, et al
     Familial adenomatous polyposis associated craniopharyngioma secondary to both germline and somatic mutations in the APC gene.
     Acta Neuropathol. 2020 Oct 6. pii: 10.1007/s00401-020-02232.
     PubMed    
     
     
     
120. GOLEBIEWSKA A, Hau AC, Oudin A, Stieber D, et al
     Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology.
     Acta Neuropathol. 2020 Oct 3. pii: 10.1007/s00401-020-02226.
     PubMed     Abstract available
     
     
     February 2020
121. LIU APY, Gudenas B, Lin T, Orr BA, et al
     Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials.
     Acta Neuropathol. 2020;139:259-271.
     PubMed     Abstract available
     
     
     
122. PFAFF E, Aichmuller C, Sill M, Stichel D, et al
     Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterations.
     Acta Neuropathol. 2020;139:243-257.
     PubMed     Abstract available
     
     
     
123. THOMAS C, Wefers A, Bens S, Nemes K, et al
     Desmoplastic myxoid tumor, SMARCB1-mutant: clinical, histopathological and molecular characterization of a pineal region tumor encountered in adolescents and adults.
     Acta Neuropathol. 2020;139:277-286.
     PubMed     Abstract available
     
     
     
124. SIEVERS P, Schrimpf D, Stichel D, Reuss DE, et al
     Posterior fossa pilocytic astrocytomas with oligodendroglial features show frequent FGFR1 activation via fusion or mutation.
     Acta Neuropathol. 2020;139:403-406.
     PubMed    
     
     
     
125. NEUMANN JE, Spohn M, Obrecht D, Mynarek M, et al
     Molecular characterization of histopathological ependymoma variants.
     Acta Neuropathol. 2020;139:305-318.
     PubMed     Abstract available
     
     
     
126. GARETON A, Tauziede-Espariat A, Dangouloff-Ros V, Roux A, et al
     The histomolecular criteria established for adult anaplastic pilocytic astrocytoma are not applicable to the pediatric population.
     Acta Neuropathol. 2020;139:287-303.
     PubMed     Abstract available
     
     
     January 2020
127. FELLER C, Felix M, Weiss T, Herold-Mende C, et al
     Histone epiproteomic profiling distinguishes oligodendroglioma, IDH-mutant and 1p/19q co-deleted from IDH-mutant astrocytoma and reveals less tri-methylation of H3K27 in oligodendrogliomas.
     Acta Neuropathol. 2020;139:211-213.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge.